EndoGlow
Private Company
Funding information not available
Overview
EndoGlow is an innovative medical device startup pioneering a novel approach to fluorescence-guided surgery. The company's core innovation, Tissue Reveal Technology (TRT), embeds fluorescence directly into surgical tools like the GreenEgg manipulator, enabling real-time tissue transillumination to reveal depth, quality, and hidden pathology. This addresses a critical unmet need in minimally invasive and robotic surgery by providing enhanced visual information where haptic feedback is absent. EndoGlow's technology is designed to integrate with existing laparoscopic and robotic systems that have near-infrared (NIR) imaging capabilities, positioning it for adoption in a broad range of soft-tissue surgical specialties.
Technology Platform
Tissue Reveal Technology (TRT): A proprietary fluorescent polymer embedded into surgical devices to provide dye-free, transilluminating fluorescence for enhanced tissue visualization during minimally invasive surgery.
Opportunities
Risk Factors
Competitive Landscape
EndoGlow competes in the surgical visualization space against injectable fluorescence dyes (e.g., ICG) and advanced imaging systems. Its unique proposition is a disposable, tool-integrated system providing transillumination, a feature not offered by perfusion-based dyes. It faces indirect competition from other advanced imaging modalities like hyperspectral imaging.